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Abstract

DIFFERENTIAL GLIAL CELL RESPONSES IN THE DENTATE GYRUS IN YOUNG
ADULT AND AGED BRAINS FOLLOWING TRAUMATIC BRAIN INJURY

By Christopher H. Shin

A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
at Virginia Commonwealth University

Virginia Commonwealth University, 2010

Advisor: Dong Sun, MD, PhD., Department of Neurosurgery

Traumatic brain injury (TBI) affects 3 out of every 1000 Americans each year, and is the
leading cause of morbidity and mortality after trauma, accounting for as many as 56,000 deaths
per year (Dutton and McCunn, 2003). The Centers for Disease and Control and Prevention
found that TBI most commonly occurs in adolescents and young adults aged from 15 to 24 years
and in the elderly (75 years and older). Following injury, the secondary injury begins almost
immediately after the primary injury and is the result of a number of cascades where once
activated, exacerbate the already altered homeostasis of the injured brain. Brain trauma leads to
complex secondary injury responses that trigger many cellular and molecular pathways,
especially inflammation. The cerebral inflammation that occurs after TBI has been described
through the processes of glial activation followed by leukocyte recruitment, and upreglation and
secretion of cytokines and chemokines. With aging there is a decrease in the production of antiinflammatory cytokines along with increasing amounts of pro-inflammatory cytokines by
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peripheral blood monoculear cells, microglia, and astrocytes. Studies have shown that
inflammation has a strong negative effect on neurogenesis in the adult brain due to the impact of
the pro-inflammatory cytokines that are released following the acute injury or disease. In this
study, we first examined the differences in glial cells responses in young adult brain and aged
brain following a moderate lateral fluid percussion injury and the correlation of glial cell
activation with hippocampal neurogenesis. We then examined the effect of anti-inflammation
treatment on glial cell response in the young and aged brain. The levels of astrocytic and
microglial responses in the DG of the hippocampus following injury at 3, 7 or 28 days postinjury were measured using densitometry image analysis on GFAP or Iba1 immunofluorescent
labeled brain tissue sections. We found that injury increased both astrocyte and microglial
activation and proliferation in both young and aged brain. The young injured animals exhibited
greater levels of GFAP while the aged injured animals exhibited greater levels of Iba1 expression
at all three time points. We also found that short time anti-inflammatory treatment with
minocycline decreased levels of Iba1 expression while increased levels of GFAP expression in
both young and aged brain following injury. Our data suggests that there are differences in glial
response in the injured young and aged brain that may contribute to the differences in the
regenerative and recovery potential in the two age groups following injury.
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Chapter 1 - Introduction:

Traumatic brain injury continues to be a serious global health concern and is gaining
more attention as new studies present the complexity of the secondary injuries that follow the
initial primarily insult. A major secondary cascade that truly attests to the complexity of treating
TBI is the inflammatory response that stems from the activation of resident microglia and
resident astrocytes. These activated microglia release a gradient of pro-inflammatory and antiinflammatory cytokines that may vary depending on the type of injury that is induced. Most
consistently, the gradient favors toward the pro-inflammatory cytokines being released at greater
amounts and can cause a recruitment of peripheral neutrophils and monocytes that cross the
ruptured blood-brain barrier to the site of injury. Once these neutrophils and monocytes are
activated as well, a potentially dangerous feed-forward loop may occur causing a continuous
induction of inflammation. TBI in the aged population has been shown to cause an even greater
detrimental effect due to the state of the brain during the course of aging. Aged brain in humans
and animal studies show that the brain possesses higher densities of resident microglia, though
they are not always in an activated state. Aged brains have seen a greater damaging effect
following TBI with larger lesion sizes, increased neuronal degeneration, an upregulated
inflammatory response, and decreased injury induced neurogenesis.
The central nervous system, once thought not possible in producing new neurons, has
shown the ability of constantly generating new cells throughout life in the neurogenic regions, ie.
the subventricular zone and the subgranular zone in the hippocampus. Studies have shown that
these newly generated neurons integrate into existing neural circuitry and become fully
functional neurons. Studies have also found that adult neurogenesis can be affected by many
factors. Among them, neural inflammation has a negative effect on neurogenesis especially in
13

the aging brain. We observed previously that TBI enhanced neurogenesis in young adult
animals; however, in the aged brain, this injury-enhanced neurogenic effect was not observed
(Sun et al., 2005). This project is set to investigate the differences of glial cells responses and its
association to neurogenesis particularly in the hippocampus in young and aged animals following
TBI. We hypothesize that the aged brain has a greater inflammatory response following TBI
which presents a greater negative effect on neurogenesis.

Epidemiology of TBI

Traumatic brain injury (TBI) is a critical health care concern affecting over 57 million
people around world, especially 1.4 million people in the United States alone each year.
(Langlois et al., 2006). Among the 1.4 million Americans that suffer TBI yearly, 1.1 million
visit the emergency department, 235,000 are hospitalized, 50,000 become deceased, and males
being twice as likely than females to experience a TBI (Langlois et al., 2006). According to
recent studies conducted by the Centers for disease control and prevention, TBI accounts for
roughly 30.5% of all injury related deaths in the United States. Falls, motor vehicle crashes,
struck by or against events, and assaults or physical retaliation are reported as the leading causes
of TBI each year (Langlois et al., 2006). Sports injuries, primarily concussions, are also a major
cause of TBI with nearly 1.6 million to 3.8 million sports-related TBI occurring yearly (Langlois
et al., 2006). Blast injuries have developed in becoming the leading cause of TBI for military
soldiers in active duty (Scott et al., 2005).
The most common age distribution of the patients experiencing a TBI has shown a bimodal trend with the first peak occurring in young adults (late teens through twenties) mostly
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due to motor vehicle crashes, and the second peak occurring among the elderly population
primarily due to falls (Rutland-Brown et al., 2006; Sendroy-Terrill et al., 2010). A patient that
has suffered a TBI may develop long-term and potential lifelong physical, cognitive, behavioral,
and emotional consequences depending on the severity of the TBI. Recently, approximately 5.3
million Americans were reported to be living with a long-term or lifelong disability due to TBI
(Thurman et al. 1999). Thus, these patients who suffer long-term problems stemming from TBI
also have difficulties in being at social events, performing daily activities, and maintaining
stability at work (Langlois et al., 2006). It has also been reported that injuries from TBI
contribute to 15.7% of injury-related productivity loss and is fourteen times greater than
compared to similar central nervous system injuries such as spinal cord injury (Finkelstein et al.,
2006). Each year $60 billion is spent annually with the money supporting the needs for patients’
medical care, rehabilitation, and loss of productivity (Thurman et al., 1999, Langlois et al.,
2006). TBI is truly a health problem whose disabling nature takes a dangerous toll on the
patients’ quality of life while representing an enormous financial burden to our country’s
economy.

Pathophysiology of TBI

Falls, motor vehicle collisions, and struck by or against interactions cause high-energy
acceleration or deceleration of the brain within the cranium (Dutton and McCunn, 2003), and can
lead to an elevation of ventricular intracranial pressure that can indicate poor outcome after TBI
(Marshall et al., 1979; Ray et al., 2002). The effects of TBI can affect patient health on two
levels beginning with the primary insult followed by a more gradual secondary injury beginning
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from minutes to hours after the primary insult and may even last months (Gentleman et al.,
2004). The primary injury arises when an external impact is delivered to the head. The initial
impact causes two different injury manifestations of TBI, focal injuries and diffuse injuries (Ray
et al., 2002). Focal injuries such as skull fractures and hematoma (epidural and subdural) are
caused by contact forces that prevent the head from moving after impact while diffuse injuries
such as concussion stem from inertial forces providing an acceleration to the head either
translationally or rotationally or both (Graham et al., 1995).
The secondary injury begins almost immediately after the primary injury and is the result
of a number of cascades where once activated, exacerbate the already altered homeostasis of the
injured brain.

Increased vascular permeability, altered ionic balance, oxidative stress,

excitotoxic damage, inflammation, and mitochondrial dysfunction are the causes of edema,
increased intracranial pressure, neuronal cell death, and ultimately neurologic impairment
(Morganti-Kossmann et al., 2002). Understanding and targeting the secondary injury phase of
TBI has been the major focus of research in order to prevent further tissue damage, stimulate
neuronal repair and neurogenesis, and restoring cognitive functions. As the brain enters the
stages of secondary injury, different mechanisms within the brain that alter cerebral blood flow,
ion homeostasis, inducing excitotoxicity, exacerbating local and systemic inflammation, and
apoptotic death of neuronal cells contribute to the ongoing effects post-injury (Ray et al., 2002).
Molecularly, oxygen free radicals are generated due to either post-traumatic ischemia from
altered cerebral blood flow (Kontos and Povlishock, 1986; Ikeda and Long, 1990; Traystman et
al., 1991, Ray et al., 2002) or the increase of intracellular free Ca2+ concentrations (Kontos and
Povlishock, 1986; Tymianski and Tator, 1996; Ray et al., 2002). Oxygen free radicals are a
threat because they damage cell membrane by lipid peroxidation and oxidize intracellular
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proteins and nucleic acids. Secondly, glutamate and aspartate, known to be excitatory amino
acids, are present in high concentrations in the extracellular space and cerebrospinal fluid after
TBI (Faden et al., 1989; Palmer et al., 1993). Aspartate and glutamate cause excitotoxicity
through its key role of serving as a ligand for NMDA receptors and AMPA receptors. It has
been documented that the increased influx of Na+ and Ca2+ ions and efflux of K+ within the
neuron leading to acute neuronal and glial swelling as well as delayed damage (Choi et al., 1987;
Reynolds and Miller, 1988; Ray et al., 2002). Furthermore, the heightened influx of Ca2+ ions
after TBI can leads to an over-activation of Ca2+-dependant proteases including calpain. Calpain
normally mediates cytoskeletal protein degradation and neurodegeneration. However, when
overexpressed, leads to harmful neurofilament protein degradation and cell death (Banik et al.,
1997).

TBI induced inflammation

During the secondary injury phase, local inflammation occurring in the brain following
injury has been widely studied. Brain trauma leads to complex secondary injury responses that
trigger many cellular and molecular pathways, especially inflammation (Raghupathi, 2004;
Ziebell and Morganti-Kossmann, 2010). The cerebral inflammation that occurs after TBI has
been described through the processes of glial activation followed by leukocyte recruitment, and
upregulation and secretion of cytokines and chemokines (Morganti-Kossman et al., 2001).
Studies throughout the literature show the dual nature of inflammation having both positive and
negative roles for the injured brain. The bimodality of inflammation has been determined
through comprehensive research and identification of the cytokines that are released in the brain.
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Inflammation provides clear benefits when it is controlled in a regulated manner for a defined
period of time (Ziebell and Morganti-Kossman, 2010). However, when inflammation is chronic
and excessive in the injured brain and it greatly contributes to many harmful processes (Correale
and Villa, 2004).
A major change occurring after TBI is the impairment of the blood brain barrier (BBB).
In the acute post-traumatic period, the leaky BBB allows for the infiltration of peripheral
monocytes, neutrophils, and leukocytes to the injured region of the brain. These activated cells
enter the brain parenchyma and release factors such as prostaglandins, free radicals, complement
factors, anti-inflammatory and pro-inflammatory cytokines (Werner and Engelhard, 2007). The
sites of leakage within the BBB become sealed by repair mechanisms; however, it is possible
that during a brief period of time, it still remains permeable to small molecules (Tanno et al.,
1992). This leads to a continuous altered state of homeostasis of the brain parenchyma and
potentially affecting neuronal function (Ziebell and Morganti-Kossmann, 2010).
Resident microglia whose function is patrolling the CNS and removing cell debris, play a
major role in the inflammatory process once activated after injury. They are constantly
surveying the microenvironment within the brain for noxious agents and injurious processes
(Nimmerjahn et al., 2005). The role of microglia has been under heavy scrutiny in determining
whether its activated response is beneficial or harmful. Microglia represents approximately 10 –
20% of the total cell population in the adult human CNS (Spranger and Fontana, 1996). These
cells belong to the mononuclear phagocyte lineage and are the primary mediators of the brain’s
innate immune response to disease, infection, and especially injury (Loane and Byrnes, 2010).
In the literature, a variety of CNS injury models have been used to investigate the role of
microglia in the inflammatory response. The microglial responses have shown varying results
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depending on the type of injury model and the severity of the injury (Loane and Byrnes, 2010).
The activation of microglia following injury causes them to undergo morphological changes (Fig
1.1). Their processes contract and their cell bodies change to an ameboid morphology while they
begin proliferating and migrating toward the site of injury (Vilhardt, 2005).
Chronic inflammation has been correlated to chronic microglial activation within the
brain. Chronic activation of microglia is considered to be the most damaging to injured or
diseased CNS because interactions occurring between damaged neurons and hyper-activated
microglia can create a self propagating positive feedback loop leading to a potential prolonged
microglial activation and neuronal cell death (Block and Hong, 2007; Gao and Hong, 2008).
Despite the harmful responses that microglia inflict onto the injured the brain, they also are key
players in beneficial responses as well. Microglia phagocytose cellular debris and maintain
normal cellular homeostasis providing preservation and protection for the brain tissue. As the
microglia are activated after injury, they have been shown to react within hours migrating toward
the site of injury. Once at the destination of injury, their processes fuse and form an area of
containment between healthy and injured tissues (Davalos et al., 2005). Following the
progression of brain injury, the role of inflammation in the injured brain may shift from
detrimental to beneficial with decreased production of pro-inflammatory cytokines and increased
production of anti-inflammatory cytokines such as IL-10 and prostaglandin E2 (PGE2) (Ekdahl
et al., 2009). A study from Bonde et al., 2006 showed that after status epilepticus induced
inflammation, neurons that survived after the first month of deleterious microglial activation
continued to survive for at least six months. Thus, it can be postulated that chronically activated
microglia potentially have a neuroprotective role (Bonde et al., 2006).

19

20

Figure 1.1: Characteristic morphologies of resting and activated microglia in the
adult rat brain. Photographs of taken from Matthieu et al. (2010). (I) Stage I: Cells
have rod-shaped cell bodies with fine, ramified processes and are defined as resting
microglial cells. (II) Stage II: activated microglia cells have elongated cell bodies with
long thick processes. (III) Stage III: activated microglia cells have small, thick processes,
and a rounded morphology. (IV) Stage IV: activated microglia cells have a rounded shape
with barely any process, vacuolated cytoplasm.
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Resident astrocytes are also important in contributing to the inflammatory process. Astrocytes
are the predominant cell type within the neurovascular unit (neurons, astrocytes, blood vessels)
having a 10:1 ratio compared to neurons in the human brain (Laird et al., 2008). Astrocytes have
been shown to contribute to the formation of the blood brain barrier, regulate cerebral blood flow
according to neuronal activity, provide metabolic substrates for neurons, and regulate oxidative
balance in the brain (Abbot et al., 1992; Janzer and Raff, 1987; Takano et al., 2006; Pellerin and
Magistretti, 2004; Wilson, 1997). Once astrocytes are activated following neurotrauma, they
undergo a phenotypic change characterized by cellular hypertrophy and hyperplasia, cytoplasmic
enlargement, elongated cytoplasmic processes, and increased expression of glial fibrillary acidic
protein (GFAP) (Casteon, 1998; Baldwin and Scheff, 1996). Reactive astrocytes, like reactive
microglia, have also been shown to exhibit a dual nature of inducing both potentially positive
and harmful reactions following TBI.
Studies have shown that reactive astrocytes following TBI form a protective scar to
contain brain injury, provide and improve niche for reparative responses, restore the integrity of
the blood brain barrier, and aid in the establishment of an environment that is helpful for neurite
outgrowth, synaptogenesis and synapse maturation through modulate levels of matrix
metalloproteinase-3 released (Sofroniew, 2005; Bush et al., 1999; Myer et al., 2006; Reeves et
al., 2002; Falo et al., 2006). However, reactive astrocytes also contribute greatly in exacerbating
inflammation following TBI. First, astrocytes are known to regulate extracellular glutamate
excitoxicity within the brain due to their expression of GLT-1 and GLAST receptors which serve
as glutamate transporters (Pawlak et al., 2005). However, after injury, these receptors are
downregulated following experimental TBI in rodents suggesting that this may lead to an
increased inflammation and exacerbated excitotoxicity (Rao et al., 1998). Astrocytes also

22

release and respond to pro-inflammatory cytokines such as TNF-α, Fas, and IL-1β and therefore,
further amplifying the inflammatory response following TBI (Laird et al., 2010).
The inflammatory cascade that ensues after TBI heavily relies on the concentration gradients
between the amounts of released pro- and anti-inflammatory cytokines. TBI causes the
upregulation and secretion of pro-inflammatory cytokines such as interleukins IL-1β, IL-6, IL-10
and tumor necrosis factor-α (TNF-α) (Ray et al., 2002). Cytokines are a group of proteins that
act as chemical messengers between immune cells. The pro-inflammatory cytokines are
believed to initiate inflammation. Generally, these cytokines are shown to be released after
tissue damage and ischemia triggering the activation of resident microglia and astrocytes and
upregulating the release of chemokines (Cederberg and Siesjo, 2010).
Looking more specifically into the roles of the pro-inflammatory cytokines, we learn that
each of these cytokines plays a pivotal role in triggering a different portion of the inflammatory
response. However, studies have also shown that these inflammatory cytokines may also have a
dual role in helping the brain recover through inflammatory response. The anti-inflammatory
cytokines such as IL-4, IL-10, IL-1Rα and TGF-β have been shown to counteract and regulate
inflammatory reactions (Cederberg and Siesjo, 2010). The expressions of chemokines are
induced leading to an upreglution of cell adhesion of molecules and mobilization of immune and
glial cells to the injured site (Ziebell and Morganti-Kossmann, 2010).

Aging brain in response to TBI

It is established that juvenile and young adult mammals recover to a greater extent than
aged adult following neurotrauma. Clinical studies examining cognitive recovery have showed
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that children exhibit greater cognitive recovery and are less-dependant on assistance than young
adults following brain injury (Eiben et al., 1984). With increasing age, the older population
show lower levels of recovery compared to their younger counterparts. For example, in
experimental TBI animal studies, three month old injured rats performed significantly better than
twenty month old aged rats on hippocampal-dependant memory tests, particularly the Morris
Water Maze following injury (Hamm et al., 1992). Changes in the CNS in response to aging are
similar to the changes that occur in other cells, and include increased oxidative stress, altered
protein accumulation, nucleic acid damage, and dysfunction of energy homeostasis. The cellular
changes during normal aging make neurons increasingly susceptible to excitotoxic damage
through the impairment of ion pumps, dysregulation of Ca2+ homeostasis, and decreased
mitochondrial function. Given that all these processes are involved in the evolution of the injury
after traumatic insult, the process of aging itself could significantly increase vulnerability and
impair the potential for recovery from TBI in aged individuals (Cekic and Stein, 2010).
Previous studies done in our lab have shown that the younger brain is capable of generating more
robust levels of cell proliferation in response to an injury compared to the aged brain, and in
accordance, the younger brain’s also showed greater levels of the newly generated neurons cells
in the hippocampus (Rolfe et al., 2009) (Fig 1.2).
Aging is generally associated with the activation of inflammatory response due to the
chronic antigenic stress on innate immunity experienced over a lifetime (Vasto et al., 2007).
With aging there is a decrease in the production of anti-inflammatory cytokines along with
increasing amounts of pro-inflammatory cytokines by peripheral blood monoculear cells,
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Figures 1.2: TBI induces cell proliferation in the DG in both young adult and aged brain.
Taken from previous studies in the Sun lab. Compared to shams, injured both young and aged
animals had significantly increased cell proliferation in both the ipsilateral and contralateral side
of the granule cell layer (GCL, A). Similarly, injured rats in both age groups had higher number
of proliferating cells in both sides of the hilus region as compared to their age matched sham (B).

26

microglia and astrocytes. In the aged brain, microglia have been shown to take on a more
activated phenotype in the resting state, and they have been shown exhibiting hypertrophic and
shortened processes that confirm a more activated cellular morphology (Chung et al., 2010).
Furthermore, studies have show that the aged brain has increased levels of IL-1β, IL-6 and TNFα expression at resting baseline levels (Gelinas and McLaurin, 2005; Godbout and Johnson,
2004; Loane and Byrnes, 2010). Microglia in the aged brain compared to those of younger
brains have been characterized to respond to injury more rapidly, produce more proinflammatory cytokines and responses, and proliferate more vigorously (Godbout et al., 2005;
Conde and Streit, 2006).
Thus, aging creates a brain environment where microglial sensitivity to immune
activation is increased leading to potential exacerbation of the secondary injury in older subjects
and severe systemic immune responses (Cekic and Stein, 2010). Exaggerated inflammation can
also interfere with neuroplasticity as the brain attempts to recover from injury along with
memory consolidation and hippocampal neurogenesis (Barrientos et al., 2006; Vallieres et al.,
2002). The aged brain gives an appearance of tissue that exists in a chronic state of
inflammation that is associated with increased immune reactivity (Dilger and Johnson, 2008). It
is well accepted that exacerbated microglial and astrocytic responses are involved in the
enhanced susceptibility to injury and poor recovery from TBI among elderly patients (Galbraith,
1987; Pennings et al., 1993; Loane and Byrnes, 2010).

Neurogenesis in the hippocampus in the adult brain
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It has been shown now through extensive research that neural stem cells give rise to the
generation of neurons and glia throughout adult life. The generation of new neurons in the adult
brain is mostly seen in two regions: the subventricular zone (SVZ) adjacent to the lateral
ventricles where newly generated neuroblasts migrate to the olfactory bulb, and the subgranular
zone (SGZ) of the hippocampal dentate gyrus where the newly generated neurons become
dentate granular neurons involving in mood modulation, learning and memory function (Franklin
and Ffrench-Constant, 2008; Ming and Song, 2005). The process of adult neurogenesis has been
described through these steps: proliferation of stem/progenitor cells, migration to appropriate
location, differentiation to region specific phenotypes, survival of immature neurons and
development of functional synaptic connectivity counteracting disease symptoms (Ekdahl et al.,
2009). Studies from our lab and others have shown that TBI and other CNS insults results in
increased levels of cell proliferation in the neurogenic areas (Sun et al., 2005; Parent, 2003).
Astrocytes have been shown to play a role in regulating almost every stage of the process of
neurogenesis including self-renewal, fast specification of adult neural stem cells (NSCs),
migration, differentiation and integration (Song et al. 2002; Barkho et al., 2006; Jiao and Chen,
2008; Mathieu et al., 2010). Although glial progenitor cells are seen to be abundant and mediate
continued production of glia throughout the brain, the natural production of new neurons is
restricted to only the SVZ and SGZ (Carpentier and Palmer, 2009).
However, despite the presence of new neurons being formed, it has been shown that only
a few newborn cells are actually incorporated into the circuitry while majority of the population
are presumed to die at the immature neuron stage through apoptosis, and the apoptotic debris is
removed from the SGZ by microglia (Ma et al., 2009, Sierra et al. 2010). Following injury, we
previously found that proximately 46% of newly generated cells persisted in the DG for an
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extended period of time and became mature granule neurons (Sun et al., 2007). Furthermore, the
newly formed neurons in the granule cell layer send axonal projections to the CA3 subfield of
the hippocampus (Sun et al, 2007) and spineless dendrites to the molecular layer (Lazarov et al.,
2010). The newly integrated neurons have been shown to display passive membrane properties,
generating action potentials, and forming synaptic inputs (van Praag et al., 2002).
With aging, as with other organs in our body, the brain also exhibits a progressive decline
in its regenerative abilities with increasing age leading to functional deterioration and poor
recovery from injury and disease. Stem cell numbers have shown to decrease with age leading
one to think that stem cell aging applies to the natural biology of aging (Sharpless and DePinho,
2007). Therefore, as NSCs are increasingly becoming acknowledged for their functional
significance and potential for repairing the injured and diseased brain, dramatic declines in
neurogenesis with age have also become an interesting topic of study (Lazarov et al., 2010). It
has been observed that both the SVZ and SGZ exhibit age-related declines in the production of
new neurons (Fig 1.3 and 1.4). Especially in the SGZ, the decreased counts of new cell
proliferation as well as newly integrated neurons are correlated with a decline in hippocampaldependant spatial memory (Bernal and Peterson, 2004).
However, despite the decline in the numbers of surviving and integrated new neurons, the
neurons that did integrate themselves appear fully functional and equivalent to those seen in the
young adult brains (Rao et al., 2005; Lazarov et al., 2010). Previous studies in our lab also
showed that aged animals showed low levels of neurogenesis following injury compared to
young adult animals (Fig 1.4).
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Figure 1.3: Generation of new neurons in the DG. Taken from previous studies in the Sun lab.
Upper panel: in younger brain, densely DCX-labeled newly generated neurons are present
throughout the GCL compared to a few DCX-labeled new neurons in the aged brain.
Bar=100µm. Lower panel: three types of DCX+ cells are observed in the GCL: A) cell with
vertically orientated soma and dendrites, B) cells with horizontally orientated soma and
dendrites, C) cell with both horizontal and vertical dendrites (mixed dendrites).
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Figure 1.4: Quantification analysis of the number of newly generated neurons in the DG
following injury. Taken from previous studies in the Sun lab. DCX+ cells which have
horizontally oriented dendrites and mixed dendrites in the GCL representing newly generated
neurons were quantified using stereological method. In young animals, injured brain have
almost double amount of DCX+ neurons compared to sham animals. In aged brain, injured rats
do not have increased number of newly generated DCX+ neurons compared to age matched
sham control.
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Influence of neuroinflammation on neurogenesis

Glial activation and especially microglia activation is a trademark of inflammation in the
CNS. Astrocytes and microglia that become activated following disease or injury produce a host
of immune mediators. Inflammation is shown to affect neurogenesis in both the SGZ and the
SVZ (Pluchino et al., 2008). Many studies have shown that the immune reaction is able to
perturb adult NSCs activity and fate through the released signaling molecules such as the
complex cascade of both pro-inflammatory and anti-inflammatory cytokines and chemokines
(Carpentier and Palmer, 2009). NSCs in the adult brain are influenced by a broad range of
inflammatory signaling molecules through their expression of receptors and ligands related to the
innate and adaptive immune responses such as toll-like receptors, cytokine and chemokine
receptors, major histocompatibility complex I (MHC I), and cell adhesion molecules (Covacu et
al., 2009; Johansson et al., 2008; Tran et al., 2007; Carpentier and Palmer, 2009). For example,
the pro-inflammatory cytokine IL-6 that is specifically expressed in lipopolysaccaride (LPS)
induced microglia, was shown to play a role in the impairment of hippocampal neurogenesis
(Monje et al., 2003). Interestingly, Song et al., 2002 showed that despite the negative and
positive effects on neurogenesis from activated astrocytes, neural progenitor cells (NPC) co
cultured with astrocytes induced a two-fold increase in NPC proliferation and a ten-fold increase
in neuronal differentiation of adult rat NPC’s.
Studies have shown that inflammation has a strong negative effect on neurogenesis in the
adult brain due to the impact of the pro-inflammatory cytokines that are released following the
acute injury or disease. The role of pro-inflammatory cytokines produced by activated microglia
and astrocytes from the acute innate inflammatory response such as IL-6, IFN-γ, IL-1β, and
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TNF-α play a pivotal role in suppressing neurogenesis. IL-6 compromises hippocampal
neurogenesis by directing the differentiation of NPCs to astrocytes through the activation of the
Janus kinase/signal transducer and activator of transcription and MAP kinase pathways
(Nakanishi et al., 2007; Whitney et al., 2009). TNF-α decreases neurogenesis by shifting the
differentiation of NPCs to astrocytes and also by inducing neuronal cell death (Peng et al., 2008).
IL-1β negatively affects neurogenesis by inducing apoptosis of NPCs through the stressactivated protein kinase/JNK pathway (Wang et al., 2007). Lastly Ben-Hur et al., 2003 showed
detrimental effects of IFN-γ on the survival and proliferation of neural stem cells and neural
progenitor cells.
Inflammation not only affects neurogenesis in the generation and survival of new
neurons, it also influences other aspects of newly generated neurons. It has been shown that
inflammatory responses guide the migration of new neurons toward ischemic damage through
the chemokine stromal cell-derived factor-1α (SDF-1α) and its receptor CXC4 (Imitola et al.,
2004). In an LPS induced neural inflammatory response, Jakubs et al., (2008) found that
inflammation not only affects the number of surviving new neurons that integrate themselves in
the SGZ, but also alters the function of survived new neurons as neurons generated during the
period of inflammation are morphologically normal yet displaying an accentuated inhibitory
responses in immature neurons and excitatory responses in mature neurons.

Minocycline as a possible treatment for TBI

Following injury or disease, a number of studies have reported the anti-inflammatory
effects of minocycline. Minocycline is a tetracycline derivative antibiotic that has been used
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extensively for its effective non-steroidal anti-inflammatory and anti-apoptotic properties (Kim
and Suh, 2009). It has been suggested that minocycline’s effectiveness is largely due to its
superior penetration of the blood-brain barrier (Saivin and Hovin, 1988; Yrjanheikki et al.,
1998). Molecularly, minocycline interferes with bacterial protein synthesis by binding to the
30S ribosomal subunit, inhibiting messenger RNA-transfer RNA interaction and protein
translation (Elewa et al., 2006).
The effects of minocycline’s anti-inflammatory properties have been demonstrated
throughout the literature in both acute and chronic brain injury (Elewa et al., 2006). Minocycline
influences neutrophils, monocytes, microglia and neurons during inflammation by inhibiting
neutrophil migration, degranulation and the formation of oxygen free radicals (Golub et al.,
1991). Despite the fact that the mechanisms of action for minocycline treatments have not been
fully understood, the beneficial effects stem from the drug’s ability to decrease or inhibit
microglia activation (Yrjanheikki et al., 1998). In an epilepsy induced animal model,
minocycline treatment decreased the number of activated microglia in the brain while increasing
the number of newborn neurons (Ekdahl et al., 2003).
The anti-apoptotic effect of minocycline has also made the drug a good candidate as a
hopeful avenue for NSC restoration and neurogenesis. Studies have showed that minocycline
prevents apoptosis by inhibiting the release of cytochrome c from mitchondria (Zhu et al., 2002),
and up-regulation of anti-apoptic protein bcl-2 mRNA levels in neurons (Matsukawa et al.,
2009). The effect of minocycline in the injured brain has been reported in several studies. For
example, Mejia et al., (2001) showed that following TBI, administration of minocycline reduced
the levels of caspase-1 (known as IL-1β converting enzyme), decreased post-traumatic lesion
size, and increased levels of cognitive recovery. In a focal TBI model, it was reported that
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minocycline decreased the density of activated microglia and lesion size without significance
effect in cognitive function or apoptosis (Bye et al., 2007). In combination with N-acetylcysteine, heightened cognitive restoration, decreased myelin lost and inhibited the production of
IL-1β was observed following a cortical impact injury (Abdel Baki et al., 2010).
Minocycline also has been shown in studies to inhibit matrix metalloproteinases (MMPs).
MMPs are proteins that are involved in degenerating extracellular proteins and extracellular
matrix components in the brain. In rat arthritis and inflammatory encephalitis models, specific
MMP2 and 9 were shown exhibiting reduced levels (Elewa et al., 2006). In summary, the
literature supports the postulation that minocycline is able to influence multiple cascades of the
secondary injury responses that occur following TBI.
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Chapter 2 - Materials and Methods

Subjects

The two groups of animals used for this study were male, Fischer 344 rats (NIA, NIH)
aged at 3 months and 20 months weighing approximately at 300 grams and 450 grams
respectively. The 3 month-old animals were housed in pairs and the 20 month-old animals were
housed individually with food and water supplied ad libitum. Both groups were housed at the
animal facility in a room that was kept at a temperature of 20 – 22 degrees Celsius following a
12-hour light/dark cycle. All procedures performed during the study complied with NIH
guidelines and approved by the Institution of Animal Care and Use Committee of Virginia
Commonwealth University.
For the first aim, a total of 9 young animals and 6 aged animals were used for the sham
GFAP densitometry data analysis along while 9 young animals and 9 aged animals were used for
the sham IBA1 densitometry data analysis. For data analysis of densitometry analysis at
different time points following injury observing both GFAP and IBA1 optical intensity: a total of
4 young animals and 4 aged animals were used for 3 dpi time point; 2 young animals and 5 aged
animals were used for 7 dpi time point; lastly, 4 young animals and 4 aged were used for the 28
dpi time point.
For the second aim, a total of 2 young rats and 2 aged rats were used for the densitometry
analysis for measuring both GFAP and IBA1 optical density following minocycline treatment.

Surgical preparation and procedure
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Following a standard protocol, a moderate lateral fluid percussion injury (FPI) was
performed to all animals used in the study. All surgical tools were sterilized through an
autoclave procedure, and surgeries were performed in an aseptic setting. Each rat from both age
groups (3 months and 20 months) endured the same surgical procedure under the same
conditions. Adult rats were anesthetized in a plexiglass chamber with 5% isofluorane, intubated
and ventilated with 2.5% isofluorane in a gas mixture (30% Oxygen, 70% nitrogen). The
animals were then secured in a stereotaxic frame. The top of their heads were cleaned and
scrubbed with Betadine to sterilize the site of incision, and Puralube ointment was placed over
their eyes to prevent dryness. A midline incision was made to expose the skull, and the
surrounding connective tissues on both sides were retracted using hemostats. Using a fitted
trephine and a Dremel drill with a small drill bit, a 4.9 mm craniotomy was made on the left
parietal bone midway between the lambda and bregma sutures (Fig 2.1). The resulting bone chip
was then removed carefully, ensuring that the dura underneath was not breached. Afterwards, a
modified Luer lock fitting was cemented onto skull over the craniotomy with an acrylic mixture.
Once the mixture was completely dry, the hub was filled to brim with saline solution in order to
check for leakage and to provide a continuous medium for the lateral fluid percussion injury
device.

Lateral fluid percussion injury and recovery

Once surgery had been completed and the Luer lock hub stabilized, the animals were then
taken off anesthesia for approximately 5 minutes or until consciousness was regained by
checking tail and toe reflexes. During this time, the fluid percussion injury device was calibrated
by repeated measurements of pressure every 30 seconds for 5 minutes, ensuring that the device
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had reached consistency in delivering the target pressure of 1.8 ± 0.05 atm (Fig 2.2). The
intubation tube was then disconnected, and the animals were transferred from the stereotaxic
frame to the fluid percussion injury device. Once the animals were connected to the injury
device through the Luer lock-fitting hub, a moderate fluid impulse (1.8 ± 0.05 atm) was
administered. Immediately following the injury, the animals were taken back to the aseptic
surgery bench in order to remove the Luer lock hub. They were then laid on a supine position
with a few pads of gauze covering the open incision, and reconnected to the intubation tube
without isofluorane for ventilation. As the animals recovered from the injury, their tail and toe
reflexes were periodically checked and recorded at the moment of first recovery response. The
righting time, the moment after injury when the animal would begin returning to an upright
position, was also recorded as the last measure of recovery. The animals were then placed under
anesthesia again with 2.5% Isofluorane as the wound was sealed using a sterile stainless steel
suture needle and 5-0 polyamide surgical suture in a simple continuous pattern. For post-surgery
treatment, the wound was covered with triple antibiotic ointment and 2% lidocaine hydrochloride
jelly. To retain body heat and provide comfort, the animals were then taken back to their cages
that had been placed on heating pads with a surgical drape providing interior bedding. After 3
hours of post surgery observation and maintenance, the rats were taken back to the animal
housing facility. Sham animals underwent the identical surgical procedures but were not given
the injury pulse.

BrdU injections
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5-Bromo-2’-deoxyuridine (BrdU, Sigma), a synthetic nucleoside that is analogous to
thymidine within the DNA, was administered to the animals in order to label newly dividing
cells after injury. Both age groups, the young adult (3 months) and aged (20 months) animals
were divided into three groups for BrdU injection. For the three-day post injury group, all rats
received a total of four intra-peritoneal (i.p.) injections of BrdU at 50 mg/kg (dissolved in sterile
saline) every two hours at forty-eight hours after injury (2 days post injury). The seven-day post
injury and twenty-eight day post injury groups also began receiving injections forty-eight hours
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Figure 2.1: Craniotomy and injury site. A 4.9 mm craniotomy was made on the left parietal
bone half way between the lambda and bregma sutures which served as the site where fluid
percussion injury was delivered.
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Figure 2.2: A photograph of a fluid percussion injury device.
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after injury. All animals in these two time groups were given single intra-peritoneal injections of
50 mg/kg per body weight daily for six days from day 2 to day 7 post injury. For clarification,
the twenty-eight day post injury group did not receive any further BrdU injections after the
seventh day post injury.
A second group of animals, consisting of both age groups of three months and twenty
month old rats, were sacrificed at the three days post injury time point also followed the same
procedure in receiving BrdU injections. This group however, was subjected to an antiinflammatory treatment.

Minocycline injections

Minocycline (Sigma) is a widely used synthetic tetracycline antibiotic with known antiinflammatory and anti-apoptic properties in several models for brain injury such as stroke and
traumatic brain injury (Elewa et al., 2006). This treatment was given to a group of 3 months and
20 months animals and sacrificed at three -day post injury (N=2 for each age group). The
animals first received 45 mg/kg of minocycline (dissolved in sterile saline, neutral pH
maintained) thirty minutes after the initial fluid percussion injury. The same dosage (45 mg/kg)
was administered again nine to twelve hours following the first injection on the same day of
surgery. On the first and second day post injury, the animals were injected twice daily with 22.5
mg/kg of minocycline at nine to twelve hours between. The protocol was consistent for both the
young adult (3 month) and aged (20 month) rats. Animals received BrdU injection at 48 hr after
injury following the protocol described above and were sacrificed at three days post injury.
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Tissue Processing

All animals, young adult and aged, were euthanized at either three days, seven days or
twenty-eight days post injury. These rats were deeply anesthetized with isofluorane until their
breathing had completely ceased, and then transcardially perfused with 400 ml of 1x Phosphate
buffer solution (PBS) followed by 400 ml of 4% paraformaldehyde + PBS solution. Afterwards,
the brains of each animal was dissected out of the skull and further fixed in 4%
paraformaldehyde + PBS solution for at least forty-eight hours. These brains were stored at 4°C
allowing for complete preservation of the freshly dissected tissue.
After 48hr fixation in 4% paraformaldehyde, the brain was stored in PBS plus 0.01%
sodium azide before slicing. On the day of making coronal sections of the brains, the 4%
paraformaldehyde + PBS solution was changed to PBS. For tissue slicing, a vibratome was then
used to make 60 µm coronal sections beginning from the rostral end of the brain, through the
hippocampus were sliced with a vibratome (Leica). The sections were collected into twenty-four
well plates filled with a PBS + 0.01% sodium azide solution, and were stored in a 4°C
refrigerator. A total of four groups consisting of thirty coronal sections were collected, filling a
total of five twenty-four well plates in order to have enough tissue available when conducting
different staining protocols.

Immunohistochemistry

For different markers, the number of sections stained varied. For fluorescent
immunostaining for GFAP (marker for astrocytes) or IBA1 (marker for microglia), two coronal
sections from a rostral and caudal section of the hippocampus 960um in between were stained.
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Sections were washed with PBS and then incubated with 3% hydrogen peroxide for 1 hr at room
temperature to block endogenous peroxidase. The brain sections were rinsed with a 1x PBS +
0.3% Triton solution for ten minutes and were blocked overnight at 4°C in blocking buffer
solution (5% normal horse serum + 1x PBS with 0.3% Triton).
The next day, the tissue sections were treated with the primary antibody solution. The
primary antibody solutions were rabbit anti-GFAP (1:1000, Dako, CA) or rabbit anti-Iba1
(1:1000, Wako) in blocking buffer solution as mentioned previously. 300 µl of the primary
antibody solution was placed in each well. The sections were incubated at 4°C for forty-eight
hours on shaker.
Once the sections were brought back to room temperature after being incubated with the
primary antibody solution, they were rinsed with 1x PBS with 0.3% triton solution for ten
minutes and repeated two more times. The sections were then blocked for three hours in
blocking buffer solution. Afterwards, the sections were given 300 µl of secondary antibody
solution and incubated at 4°C overnight. The secondary antibody solution was prepared with a
1:200 dilution of Alex Fluor 488 anti-rabbit IgG (Invitrogen) in blocking buffer solution.
Upon the completing the incubation with the secondary antibody solution, the sections
were brought back to room temperature, washed with 1x PBS for ten minutes three times, rinsed
with distilled water (dH20) and mount the finished tissue sections onto glass microscope slides
coverslipped with Vestorshield (Vector Lab).

Immunofluorescent double-label staining
The selected coronal sections were rinsed twice with PBS for five minutes, and then
denatured in a 50% formamide solution at 65°C for one hour. Sections were then rinsed with 2x
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saline sodium citrate (SSC) for five minutes at room temperature. The sections were further
denatured in 2N hydrochloric acid (HCL) for thirty minutes at 37°C. Following the completion
of the denaturation process, the sections were rinsed twice with PBS for five minutes each wash.
Once the PBS washing was complete, the tissue sections were treated with 3% hydrogen
peroxide for one hour at room temperature to block endogenous hydrogen peroxidase.
The primary antibodies used were anti-mouse BrdU combined with anti-rabbit GFAP (1:200 for
BrdU, 1:1000 for GFAP; Dako, CA) or anti-mouse BrdU with anti-rabbit Iba1 (1:200 for BrdU,
1:1000 for Iba1, Wako). The secondary antibody solution was prepared with a 1:200 dilution of
an Alexa Fluor 488 anti-mouse IgG along with a 1:200 dilution of an Alexa Fluro 568 anti-rabbit
IgG in blocking buffer solution. After incubation with the primary and secondary antibodies, a
4', 6-diamidino-2-phenylindole (DAPI) solution (1:1000 in PBS) was then added to the tissue
sections for a ten-minute incubation for nuclei staining. Lastly, the sections were washed with
1x PBS three times and then each section was quickly rinsed with distilled water before they
were mounted onto glass slides and coverslipped with Vectorshield (Vector Labs, CA) and
sealed with nail polish.

Densitometry Image Analysis

This procedure was used to measure the fluorescent optical intensity of GFAP and Iba1
staining. This procedure allowed us to compare the fluorescent optical intensity between the
three-month and twenty-month age groups as well as the different time points post injury of a
particular cell specific marker.
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The fluorescent antibody tagged tissue sections were examined under a 4x objective lens
on an Olympus fluorescent microscope. The sections were then scanned under a 488 nm or 568
nm wavelength light measurements in order to visualize the specific glial cells that had been
labeled with GFAP or Iba1. To set the exposure time, sections from sham animals for each time
point were used as reference points. This was an important step in the protocol because the
tissue samples that were used for this experiment were not all stained for the specific cell
markers at the same time. Some samples that were examined for this quantification study had
previously been stained and photographed from past experiments. Therefore, it was imperative
in finding the closest reference point so that the different age groups at different time points post
injury could be compared. Once the exposure time of the sham groups was set, the ipsilateral
dentate gyrus region in the hippocampus was photographed for all the tissue sections.
The photo files were then transferred to the computer program IPLAB, a densitometry
program that was used to measure the amount of fluorescent optical intensity of glial cells
marked with a specific fluorescent antibody within a region of interest. The segmentation
feature of this program was the main tool for measuring fluorescent intensity. This feature was
designed to mark and overlap the areas of fluorescence detected. Therefore, the settings placed
on this feature also had to be controlled in order to prevent from over or under coverage of
fluorescence. This was also done by adjusting the minimum and maximum sensitivity of
coverage to the sham animal groups within each time point post injury. Once the segmentation
level was determined, the region of interest was then traced over the photo of the dentate gyrus.
The two regions of interest analyzed were the granule cell layer and the hilus regions. Stringent
settings were also placed so that no overlapping fluorescent signals between both regions of
interest would occur. This was important in confirming that the regions of interest drawn were
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providing clear boundaries for analysis. The photos were also measured at grayscale in order to
place all tissue sections on an equal optic background.
Once the numerical data was obtained from each section measured, it was copied to an
excel spreadsheet. Since the staining of the tissue sections was conducted over different time
points, setting consistent standards for the sham animal groups first allowed us to use the raw
data of fluorescent optical intensity measured from the regions of interest. Another important
part of this procedure was that a young adult and aged sham animal group was included for each
time point post injury. This was necessary in order to ensure that we were able to measure a
change in fluorescent optical intensity from sham animal groups to injured animal groups. This
allowed us the ability to also compare between the young and aged groups because once the
sham young levels were set first, these settings were then held consistent throughout each batch
of tissue sections for their respective time point, allowing us to look at the normalized changes in
GFAP or IBA1 expression at each time point compared to their sham groups.

Confocal microscopy

This procedure was used to quantify the number of immunofluorescent double labeled
cells that were marked with either GFAP and BrdU or IBA1 and BrdU. The granule cell layer
regions of the tissue sections were examined on a Leica confocal microscope (TCS SP2 model)
under a 40x oil immersion lens. The entire span of the granule cell layer on the ipsilateral side of
the injury was examined by looking through its entire thickness in order to examine every BrdUpositively labeled cell. Only BrdU-specific fluorescently labeled cells with an unambiguous
nucleus was deemed a positive cell. Double labeling with either Iba1 was seen through the
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multiple channels that were set to co-visualize the different light intensities of each fluorescent
antibody. For quantification, the total numbers of BrdU-positive cells were compared to the
number of cells that were positive for BrdU and either Iba1 or GFAP.

Data analysis

All statistical analysis of data was done using SPSS software. A univariate ANOVA was
used to determine any statistically significant differences in densitometry analysis and cell
quantification data. Post-hoc student t-tests (only two-tail t-tests were considered) were used to
determine differences within groups within groups when cross comparing between the young and
the aged animal groups, with p-values less than 0.05 being considered statistically significant.
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Chapter 3 - Results

In preliminary studies conducted in our lab, we found that the aged brain exhibited
increased expression of inflammatory cell markers such as Iba-1, ED1, and GFAP in the dentate
gyrus of the hippocampus following TBI. We have also found that the aged brain shows
decreased neurogenic capacity in the hippocampus following injury. Based on these
observations, this study sought to establish the connection between the heightened levels of
inflammatory cell responses and decreased levels of neurogenesis in the injured aged
hippocampus by comparing the degree of glial cell responses and neurogenic cell response
following injury between aged brains and younger brains. The first aim is to examine the
differences of glial cell responses in the aged and younger brains. The second aim is to assess
whether an anti-inflammation treatment with minocycline will down regulate the injury-induced
inflammatory cell response and upregulate neurogenesis in the aged and young brains. For the
first aim, brain tissue samples from twenty-three 20 month-old Fisher 344 rats and twenty-three
3 month-old Fisher 344 rats were used. For Aim2, a total of six Fisher 344 rats at 20 months of
age along with six Fisher 344 rats at 3 months of age were used.

Morphological changes of astrocytes and microglia following TBI

Following injury, astrocytes and microglia transformed morphologically and functionally
from a resting, inactivated state to a more robust, activated state. The morphological differences
between resident microglia and astrocytes compared to their activated counterparts were
observed within the dentate gyrus of the hippocampus. Compared to the resident microglia
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mostly seen in sham animals, activated microglia showed an increased size of cell body and
shorter projections as a result of TBI (Fig 3.1 a-b). Compared to inactive astrocytes, activated
astrocytes also showed increased density and size of the cell bodies while displaying an increase
in the length and thickness of their projections following TBI (Fig 3.1 c-d). These
morphological changes were consistent in the observed granule cell layer and hilus regions
within the hippocampus.

Levels of GFAP expression at different time points in the dentate gyrus following TBI

GFAP, an intermediate filament protein expressed by astrocytes, is used as a marker for
astrocyte activation. The level of GFAP expression was quantified using densitometry analysis.
GFAP expression in sham young and aged animals was used as the standard for comparison for
their respective injured groups. The levels of GFAP expression at different time points after
injury in the injured animals were measured in granule cell layer (including the SGZ) and the
hilus regions in the dentate gyrus of the hippocampus. The granule cell layer and the hilus
regions were analyzed separately.
We found that the sham young animals displayed greater GFAP expression in both the
granule cell layer and hilus regions compared to the aged sham animals (Fig 3.2). However, the
differences between the young and aged animal groups in both regions were not statistically
significant (Fig 3.2).
Following TBI, in the young injured animals, GFAP expression was increased at 3 and 7
days post injury (dpi) while showing decreased levels at 28 dpi time point post-TBI in both the
GCL and hilus regions in the dentate gyrus (Fig. 3.3). GFAP expression was greatest at 7 days
post injury in both the GCL and hilus regions (Fig 3.3 C). Statistical analysis revealed that in the
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GCL region, compared to the sham group, the optical intensity levels measured at 3 dpi and 7dpi
were significantly greater (Fig 3.5 a, p = 0.02 and p = 0.003 respectively) while the 28 dpi time
point did not show a significant difference (Fig 3.4 a). When comparing the optical intensity
within the young injured group at different time points, GFAP expression at 7 days post injury
between 28 days post injury reached a statistic significance (p = 0.019) (Fig 3.4 a). Statistical
analysis in the hilus region showed that GFAP expression in the injured animals was
significantly higher in the 7dpi and 28 dpi time points compared to sham group (Fig 3.4 b, p =
0.033 and p = 0.014 respectively) whereas the 3 dpi time point compared to the sham group did
not reach significance. Optical intensity measured between the different time points following
injury did not show statistical significance.
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Figure 3.1: Morphological changes of microglia and astrocytes following injury.
Photographs taken from sections stained with Iba1 or GFAP in the ipsilateral DG. (a) Resting
microglia displays a smaller cell body, long and thin processes. (b) Activated microglia
possesses a larger cell body and short, sturdy processes. (c) Resting astrocytes display a smaller
cell body and short star-like processes; (d) Activated astrocytes display bigger cells bodies and
longer, thicker processes.
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Figure 3.2: Comparison of baseline GFAP expression in sham young and aged rats with
quantitative analysis of the degree of GFAP fluorescent optical intensity in both the GCL
and hilus regions in the DG. Photographs taken from GFAP stained coronal sections in the
ipsilateral DG from sham young (A) and aged animals (B). (C) Densitometry analysis showed
that in the GCL (SGZ included), compared to the sham aged animals, sham young animals had a
greater level of baseline GFAP signaling intensity but the difference was not significant (F1, 13 =
2.718, p = 0.123). The hilus region of the sham young animals also had a greater baseline GFAP
optical intensity levels when compared to the sham aged animals but the difference was not
significant (F1, 13 = 3.258, p = 0.094). Error bars represent the standard error mean.
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Figure 3.3: Astrocytic response following TBI in the young adult rat brain at 3, 7 and 28
days post injury. Photographs taken from GFAP stained coronal sections in the ipsilateral DG
of the hippocampus in sham animal, 3, 7 and 28 days post injury. Graph represents densitometry
analysis of GFAP staining intensity at different time points. In the GCL, measured GFAP
optical intensity levels were significantly greater at the 3 dpi (*p < 0.05) and 7 dpi time points
post-injury (**p < 0.01) compared to sham animal groups. The differences of GFAP optical
intensity compared between the 7 dpi and 28 dpi time points showed a significant difference (*p
< 0.05). In the hilus region, GFAP optical intensity levels was significantly greater compared to
sham young animal groups at the 7dpi and 28 dpi time point post-injury (* p < 0.05).
Differences between the GFAP intensity levels within the different time points did not show
significance.
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In the aged injured animals, GFAP expression was increased at 3 and 7 days post injury
while showing decreased levels at 28 dpi time point post-TBI in the GCL while the hilus region
in the showed a gradual increasing trend (Fig. 3.4). GFAP expression was greatest at 3 days
post injury in the GCL region and at 28 days post injury in the hilus region (Fig 3.4). Statistical
analysis revealed that in the GCL region, compared to the sham group, the optical intensity
levels measured at 3 dpi and 7dpi were significantly greater (Fig 3.4, p = 0.002 and p = 0.002
respectively) while the 28 dpi time point did not show a significant difference. When comparing
the optical intensity within the aged injured group at different time points, GFAP expression at 3
days post injury between 28 days post injury reached a statistic significance (Fig 3.4, p = 0.044).
Statistical analysis in the hilus region showed that GFAP expression in the injured aged animals
was significantly higher in the 7dpi and 28 dpi time points compared to sham group (Fig 3.4, p =
0.038 and p = 0.019 respectively) whereas the 3 dpi time point compared to the sham group did
not reach significance. Optical intensity measured between the different time points following
injury did not show statistical significance.
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Figure 3.4: Astrocytic response following gTBI in the aged brain at 3, 7, and 28 day post
injury. Photographs taken from GFAP stained coronal sections in the ipsilateral DG of the
hippocampus in sham animal, 3, 7 and 28 days post injury. Graph represents densitometry
analysis of GFAP staining intensity at different time points. In the GCL, measured GFAP
optical intensity levels were significantly greater at the 3 dpi and 7 dpi time point post-injury
compared to sham animal groups (** p < 0.01). The differences of GFAP optical intensity
compared between the 3 dpi and 28 dpi time point reached significance (*p < 0.05). In the hilus
region, GFAP optical intensity levels were also significantly greater compared to sham aged
animal groups at 7 dpi and 28 dpi time points post-injury (* p < 0.05). Differences between the
GFAP intensity levels within the different time points in the injured groups did not show
significance.
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Cross comparison of astrocyte activation between young and aged injured animal groups

Compared to the aged groups, the young adult animal groups displayed greater levels of
GFAP optical intensity in sham animal and in injured groups in all three post injury time points in
both the GCL and hilus regions. However, two tail t-test analyses revealed that the differences
between two groups were no statistically significant in both GCL and hilus regions (Fig 3.5).
Secondly, we looked at the normalized data in order to examine the changes in optical intensity
compared to sham groups at each time point. Using our sham groups as a baseline 100%, the
respective young and aged animals were then examined by looking at their difference from the 100%
frame of reference. Compared to the young groups, the aged animal groups displayed greater levels
of GFAP optical intensity changes at all three post injury time points in both the GCL and hilus
regions. Again, at each time point the optical intensity measured was compared to sham levels.
However, two tail t-test analyses revealed that the differences between two groups were no
statistically significant in both GCL and hilus regions (Fig 3.6).
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Figure 3.5: Comparison GFAP expression between aged and young animal groups in both
the GCL and hilus regions. In the GCL and hilus regions, measured GFAP optical intensity
levels displayed that younger animals both sham and injured at all three time points were greater
than the aged animals. However, two-tail t-test analysis showed no statistical significance
between the groups at each time point.
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Figure 3.6: Normalized comparison of GFAP expression between aged and young animal
groups in both the GCL and hilus regions. In the GCL and hilus regions, the normalized
GFAP optical intensity levels displayed that younger animals at all three time points showed less
changes relative to sham groups than the aged animals. However, two-tail t-test analysis showed
no statistical significance between the groups at each time point.
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Levels of microglial marker Iba1 expression at different time points in the dentate gyrus following
TBI

Microglia is described as the resident macrophages in the brain parenchyma, and they
comprise approximately 15% of the total cells within the brain (Mathieu et al., 2010). Once
microglia are activated following a traumatic insult or disease, they release a series of
inflammatory cytokines into the brain. They are the major players that contribute to the
inflammatory response due to their release of pro-inflammatory cytokines which cause a positive
feedback loop creating a potentially dangerous state for the brain that is exacerbated especially in
the aged population.
To assess the level of injury-induced microglia activation, we used Iba1 as a marker to
label microglia. Iba1 is a calcium binding protein expressed by resting and activated microglia.
The Iba1 staining intensity in the GCL and hilus of ipsialteral DG was quantified using
densitometry analysis. Similar to GFAP quantification, Iba1 staining in the sham brain was used
as the standard for comparison. In sham both young and aged animal, Iba1-labeled microglia are
predominant at resting state with small irregular nuclear and fine slender processes.
Densitometry analysis revealing that the baseline microglia Iba1 expression was higher in the
aged sham compared to the sham young animal group in both the GCL and the hilus regions
(Fig. 3.7). ANOVA analysis showed that the differences of Iba1 optical intensity between the
sham aged and sham young were not statistically significant in the GCL region (Fig 3.7, F1, 16 =
2.812, p = 0.113). In the hilus region, statistical analysis showed that the sham aged animal
group exhibited a significantly greater levels of IBA1 measurements compared to the sham
young group (Fig 3.7, F1, 16= 4.538, p = 0.049).
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Figure 3.7: Comparison of baseline microglial Iba1 expression in sham young and aged
rats with quantitative analysis in both the GCL and hilus regions in the DG. Photographs
taken from Iba1 stained coronal sections in the ipsilateral DG from sham young and aged
animals. Densitometry analysis revealed that in the GCL (SGZ included), compared to the sham
young animals, sham aged animals had a greater level of baseline Iba1 expression but the
difference was not significant (F1, 16 = 2.812, p = 0.113). In the hilus region, the sham aged
animals also had a greater baseline Iba1 optical intensity levels when compared to the sham
young animals and the difference was significance (* p < 0.05)
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Following injury, in the young injured animals, Iba1 expression was increased at 3 dpi
and 28 dpi while showing decreased levels at 7 dpi in the GCL region. In the hilus region, IBA1
showed an increasing trend in optical intensity levels measured at each successive time point
(Fig. 3.8). Iba1 expression was greatest at 28 days post injury in both the GCL and hilus regions
(Fig 3.8). Statistical analysis revealed that in the GCL region, the optical intensity levels
measured at 3 dpi and 28 dpi were significantly greater compared to the sham young group (Fig
3.8, p = 0.001 and p = 0.003 respectively) while the 7 dpi time point did not show a significant
difference (p = 0.132). When comparing the optical intensity within the injured groups at
different time points, the differences were not statistically significant. In the hilus region, Iba1
expression in the injured animals was significantly higher at the 3 dpi, 7dpi and 28 dpi time
points compared to sham group (Fig 3.8, p = 0.003, p = 0.014 and p = 0.001 respectively).
Optical intensity measured between the different time points following injury in the hilus region
did not show statistical significance.
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Figure 3.8: Microglial cell response following TBI in the young adult brain at 3, 7, and 28
day post injury. Photographs taken from Iba1 stained coronal sections in the ipsilateral DG of
the hippocampus in sham animal, 3, 7 and 28 days post injury. Graph represents densitometry
analysis of Iba1 staining intensity at different time points. In the GCL, measured Iba1 optical
intensity levels were significantly greater at the 3 dpi and 28 dpi time points post-injury
compared to sham animal groups (**p < 0.01). In the hilus region, Iba1 optical intensity levels
at all three time points post injury were significantly greater compared to sham animal groups
(**p < 0.01).
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In the injured aged animals, Iba1 expression was increased at 3 dpi and 28 dpi while
showing decreased levels at 7 dpi in the GCL and the hilus region had a gradual increasing trend
(Fig. 3.9). Iba1 expression was greatest at 28 days post injury in both the GCL and hilus regions
(Fig 3.9). Statistical analysis revealed that in the GCL region, compared to the sham group, the
optical intensity levels measured at 3 dpi and 28 dpi were significantly greater (Fig 3.9, p =
0.009 and p = 0.009 respectively) while the 7 dpi time point did not show a significant
difference. When comparing the optical intensity within the aged injured group at different time
points, Iba1 expression did not reach statistic significance. Statistical analysis in the hilus region
showed that Iba1 expression in the injured aged animals was significantly higher in the 7dpi and
28 dpi compared to sham group (Fig 3.9, p = 0.017 and p = 0.002 respectively) whereas the 3 dpi
did not reach significance when compared to the sham group. Optical intensity measured
between the different time points following injury did not show statistical significance.

Cross comparison of microglial activation between young and aged injured animal groups

The aged injured animal group displayed greater levels of Iba1 optical intensity in sham
and injured groups at all three time points in the GCL and hilus regions. Two tail t-tests were
applied to assess the levels of significance between the levels of Iba1 optical intensity from the
injured aged and injured young animal groups. There were no significant differences of Iba1
optical intensity at each post injury time point as well as the sham groups in both the GCL and
hilus regions (Fig 3.10). Secondly, looking at the normalized comparison, the aged injured
animal group displayed lower levels of Iba1 optical intensity in compared to sham groups at all
three time points in the GCL and hilus regions. Two tail t-tests were applied to assess the levels
of significance between the levels of Iba1 optical intensity from the injured aged and injured
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young animal groups. Only at 3 dpi time point, a significant difference of Iba1 optical intensity
change was found (Fig 3.11, p = 0.012).

77

78

Figure 3.9: Microglial cell response following TBI in the aged brains at 3, 7, and 28 day
post injury. Photographs taken from Iba1 stained coronal sections in the ipsilateral DG of the
hippocampus in sham animal, 3, 7 and 28 days post injury. Graphs represent densitometry
analysis of Iba1 staining intensity at different time points. In the GCL, measured Iba1 optical
intensity levels were significantly greater at the 3 dpi and 28 dpi compared to sham animal
groups (**p < 0.01). In the hilus region, Iba1 optical intensity levels were also significantly
greater at the 7 dpi and 28 dpi compared to sham aged animal groups (*p < 0.05 and **p < 0.01).
There were no significant differences within the GCL and hilus regions between the different
injury time points following TBI.
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Figure 3.10: Comparison of Iba1 expression between injured aged and young animal
groups at 3, 7, and 28 dpi in both the GCL and hilus regions. In the GCL and hilus regions,
measured Iba1 optical intensity levels displayed that injured aged animals were greater than
injured young animals at all time points. However, two-tail t-test analysis showed no
significance between the injured young and aged groups at each time point.
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Figure 3.11: Normalized comparison of Iba1 expression between injured aged and young
animal groups at 3, 7, and 28 dpi in both the GCL and hilus regions. In the GCL and hilus
regions, measured Iba1 optical intensity levels displayed that injured aged animals were greater
than injured young animals at all time points. A two-tail t-test analysis showed significance
between the injured young and aged groups at each time point at the 3 dpi time point (*p < 0.05).
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Percentage of inflammatory cells among injury-induced newly generated cells in the DG in both
young and aged animal groups

In previous studies done in our lab, we found that TBI enhances cell proliferation in the
injured DG in both young and aged brains (Fig.1.2). In order to determine whether
inflammatory cells count for the injury-induced proliferating cell population, coronal brain
sections from animals sacrificed at either sham, 3 days or 28 days post-injury in both young and
aged animals were processed for immunofluorescent double-labeling for mitotic marker BrdU
and microglia marker Iba1. Immunofluorescent stained sections were examined using a Leica
confocal microscope. BrdU and Iba1 double-labeled cells in the GCL of the ipsilateral DG were
quantified. At 3 days post injury, sham young animals displayed a 3.85% co-labeling of BrdU
and Iba1. In the injured young animals, around 87.21% BrdU/Iba1 double-labeling was
observed. In comparison with the younger counterparts, aged sham animals at 3 days post-injury
had 10.21% BrdU/Iba1 double-labeling. Aged injured animals had 84.10% BrdU/ Iba1 colabeled cells.
At 28 days post injury, young sham animals displayed 5.95% of BrdU positive cells that
were co-labeled with Iba1, and injured young animals with 38.7% co-labeling of BrdU and Iba1.
In the aged counterparts, sham animals displayed 55.2% of BrdU positive cells that were colabeled with IBA1, while aged injured animals maintained a high percentage of BrdU and Iba1
double labeling at 81.7% (Fig.3.12).
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Figure 3.12: Differentiation of newly-generated cells into microglia. Confocal images
showing A) newly generated BrdU-labeled cells in the GCL indicated by arrow; B) microglia
identified by fluorescent Iba1 immunostaining indicated by arrow; and C) co-labeling of newly
generated BrdU positive cell with Iba1. Graphs show the percentage of BrdU/Iba1 doublelabeled cells in the GCL at 3 and 28 days post-injury in both young and aged brains. Cells in the
GCL which were co-labeled with BrdU and Iba1 were calculated as a percent of co-labeling of
against the total number of BrdU-positive cells.

86

Effect of anti-inflammation treatment with minocycline on glial cell responses in the
hippocampal dentate gyrus at 3 days post-injury

Minocycline is a tetracycline derivative antibiotic which has anti-inflammatory
properties. In order to assess whether minocycline’s anti-inflammatory abilities can significantly
decrease inflammatory cell responses in the injured brain, young and aged animals were
subjected to a moderate L-FPI followed by a short minocycline treatment. Animals were
sacrificed at 3 days post-injury and processed for immunofluorescent labeling of IBA1 or GFAP.
The staining intensity of IBA1 and GFAP was quantified using densitometry image analysis.
For GFAP staining, the young injured animals treated with minocycline showed a
significant increase in GFAP optical intensity especially in the GCL region compared to sham
and injured non-treated animals (Fig 3.13, p = 0.001 and p = 0.035 respectively). In the hilus
region, the young injured animal treated with minocycline also showed an increase in GFAP
optical intensity compared to sham and injured non-treated animals. However the statistical
analysis showed no significance (Fig 3.13). The effects of minocycline treatment on the GFAP
optical intensity following TBI in the injured aged animal counterparts also showed an increase
in both the GCL and hilus regions. In the GCL region, statistical analysis showed a significant
increase in treatment animals compared with the sham animal group (p = 0.018) but no
significance between the injured aged group and the aged treatment animals (Fig 3.13). In the
hilus region, there were no statistical significant increases between groups (Fig 3.13). However,
the treatment group compared to the sham group almost reached a significant increase (p =
0.058).
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For microglia IBA1 staining, the young injured animals had a decrease in IBA1 optical
intensity following minocycline treatment in both the GCL and hilus regions (Fig 3.14). In the
GCL and hilus regions, there were no statistical significances between groups. However, in the
hilus region of the injured young animal groups, the decreased levels of IBA1 optical intensity in
the young treatment group compared to non-treatment injury group almost reached significance
(p = 0.085). In the aged injured animal groups, IBA1 staining intensity was decreased in the
injured brain following minocycline treatment was seen in both the GCL and hilus regions (Fig
3.14). In the GCL region, the aged treatment group compared to the non-treated injured aged
group almost reached significance (p = 0.074). In the hilus region, despite the decreased levels
of IBA1 optical intensity, there was no significance when compared to either the sham or nontreated injured aged animal groups.
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Figure 3.13: Quantitative analysis of astrocyte GFAP levels in the DG of injured young and
aged animals at 3 days post-injury. A) In the young adult groups, significance in GFAP
labeling was seen when comparing injured young animal groups to sham group (**p = 0.035),
between the sham young animal groups and injured minocycline treated group (**p = 0.014),
and between the treated young group to sham young groups in the GCL region (#p = 0.001). (B)
In the aged GCL, significance in GFAP labeling was seen when comparing sham aged animal
group to the treatment aged group (**p = 0.010), between the sham aged animal groups and
injured (**p = 0.018). C) In the hilus region for the young animal group, though increased
GFAP optical intensity levels were seen, there was no statistical significance between group
comparisons. D) In the hilus region for the aged animal group, though increased GFAP optical
intensity levels were seen, there was no statistical significance between group comparisons.
Comparison between the sham aged animals and the treatment aged groups almost reached
significance (*p = 0.058).
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Figure 3.14: Quantitative analysis of microglial IBA1 expression levels in the DG of injured
young and aged animals at 3 days post-injury. A) Significance in IBA1 labeling was seen
when comparing the sham young animal groups and injured (**p = 0.001) (B) In the aged GCL,
significance in IBA1 labeling was seen when comparing sham aged animal group to the injured
aged group (**p = 0.004). C) In the hilus region for the young animal group, though decreased
IBA1 optical intensity levels were seen following treatment, there was statistical significance
between sham young and injured young animals (**p = 0.001). D) In the hilus region for the
aged animal group, though decreased IBA1 optical intensity levels were seen following
treatment, there was statistical significance between sham aged and injured aged animals (**p =
0.011). Note in both young and aged brains in the GCL and hilus regions, IBA1 expression was
decreased in the micocycline treated groups.
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Chapter 4 - Discussion

Results Summary

In this study, we first utilized coronal brain sections containing the hippocampus from
previous studies done in our lab to compare the TBI-induced glial responses in the dentate gyrus
of the hippocampus between 3-month old young adult and 20-month aged brains. We have
found that aged rats had lower level of baseline expression of astroglial marker GFAP and higher
level of baseline expression of microglial marker Iba1 in comparison to the younger
counterparts. Following injury, in the young injured animal groups, astrocyte GFAP staining
was increased at 3, 7, and 28 days post injury, and was peaked at 7 days post injury in both GCL
and hilus regions. The aged injured animal groups also showed increased GFAP staining
following injury. The highest GFAP staining was observed at the 3 and 7 days post injury for the
GCL and hilus regions, respectively. Following injury, microglial Iba1 expressed was increased
and was seen at the greatest at the 28 days post injury in the GCL and hilus regions for both
young and aged animals. In summary, moderate LFPI had a significant and similar effect on
glial responses in dentate gyrus in both young and aged animals.
After examining the level of injury induced glial responses in the DG, we next assessed
the degree of TBI-induced generation of new microglial cells using BrdU and Iba1 doublelabeling. We found that at 3 days post injury, both injured young and aged animals had a high
percentage of double labeling of BrdU and Iba1. At 28 dpi, the measured levels of BrdU and
Iba1 double labeled cells decreased in the young injured animal group whereas the aged injured
animal group maintained high levels of BrdU and Iba1 double labeling. This suggests that TBI
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not only induces microglia activation through morphological changes but also through increasing
cell numbers and this is more pronounced in the aged brain.
Lastly, we assessed the effect of anti-inflammatory treatment with minocycline on glial
cells responses in both young and aged brains. Short time minocycline treatment increased
GFAP expression while decreased Iba1 expression in both young and aged animal groups in the
GCL and hilus regions.

Sham aged rats have higher baseline level of microglial Iba1expression and lower level of GFAP
expression compared to sham young animals

Aging is generally associated with the activation of inflammatory response due to the
chronic antigenic stress on innate immunity experienced over a lifetime (Vasto et al., 2007). We
found in this study that sham aged animals exhibited greater levels of Iba1 fluorescent optical
intensity in both the GCL and in the hilus regions compared to the sham young adult animals.
The greater levels of measured Iba1 were probably due to the increased size of resting state
microglial and the higher numbers of resident microglial cells in the aged brain. Our findings
were in agreement with observations from other published studies report that the aged brain
shows a chronic state of inflammation that is associated with increased immune reactivity
(Dilger and Johnson, 2008). Furthermore, in the aged brain, microglia have been shown taking
on a more activated phenotype in the resting state, and they have been shown exhibiting
hypertrophic and shortened processes that confirm a more activated cellular morphology (Chung
et al., 2010).
In this study, we also found that sham young adult animals exhibited higher GFAP
expression than the aged brain. Astrocytes are the predominant cell type within the

94

neurovascular unit (neurons, astrocytes, blood vessels) having a 10:1 ratio compared to neurons
in the human brain (Laird et al., 2008). In the uninjured CNS, astrocytes provide many
supportive activities essential for neuronal function such as homeostatic maintenance of pH and
the extracellular ionic environment, and providing metabolic substrates for neurons (Sofroniew,
2005). Therefore, the lower levels of GFAP optical intensity in the sham aged animals could
potentially be postulated that aged animals may have less neuronal support. In contrast to our
results, other studies have shown that there is an age-related increase in basal expression of
GFAP mRNA and protein levels in rodents and humans (Yoshida et al., 1996). Also, age related
increases in GFAP mRNA or protein in extracts of the whole hippocampus have been attributed
to more GFAP molecules per cell (Major et al., 1997). The disparity between our results and
others may due to the methods used. This study used densitometry analysis of anti-GFAP
fluorescent antibodies as markers to quantify GFAP. Compared to other methods for protein
analysis such as Western blotting, the densitometry image analysis we used is less accurate while
providing spatial benefits. Human errors could happen during the immuno-fluorescent staining,
photo taking as well as during imaging analysis. Furthermore, our study focused only on the
GCL and hilus regions of the dentate gyrus in the hippocampus while other studies accounted for
the entire hippocampus including the CA1 and CA3 regions as well as the dentate gyrus which
may affect the measured levels of GFAP.

Microglia response in young adult and aged brains following TBI

Microglia are the primary intrinsic immune effecter cells of the central nervous system
and are involved in most pathological processes of brain related to inflammation (Berman et al.,
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1999). Our study revealed significant microglial activation through increasing in number and
size in both young and aged brains following injury. We also showed that the aged animals had
higher levels of optical intensity of IBA1 in sham baseline level and following injury at all three
time pointes examined compared to the young animal groups, though the differences did not
reach statistical significance. However, when the changes in IBA1 expression at each time point
were compared between young and aged animal groups, significance was found at the 3 dpi time
point.
Studies have shown that chronic activation of microglia is considered to be the most
damaging to injured or diseased CNS because interactions occurring between damaged neurons
and hyper-activated microglia can create a self propagating positive feedback loop leading to a
potential prolonged microglial activation and neuronal cell death (Block and Hong, 2007; Gao
and Hong, 2008). Furthermore, microglia in the aged brain compared to those of younger brains
have been characterized to respond to injury more rapidly, produce more pro-inflammatory
cytokines leading to more pronounced inflammatory responses, and proliferate more vigorously
(Godbout et al., 2005; Conde and Streit, 2006). More specifically, the aged brain has increased
levels of the pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α expression at resting
baseline levels while greatly increasing in production following injury or insult to the CNS
(Gelinas and McLaurin, 2005; Godbout and Johnson, 2004; Loane and Byrnes, 2010). Thus,
aging creates a brain environment where microglial sensitivity to immune activation is increased
leading to potential exacerbation of the secondary injury in older subjects and severe systemic
immune responses (Cekic and Stein, 2010).
In our study, we found that Iba1 optical intensity was lower at 7 than 3 and 28 days post
injury in both aged and young animal groups. This maybe due to a rapid regression of injury-
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activated microglial cells at this time points compared to at 3 days post injury, and the injuryinduced newly generated microglia cells contributing to the second wave of high Iba1 expression
at 28 days post injury. A study by Sandhir et al., (2008) quantified Iba1 mRNA levels following
the induction of controlled cortical impact injury and found highest levels of Iba1 mRNA at the 3
dpi time point supporting our observation. The Sandhir study also found that the aged animal
groups had greater Iba1 levels compared to young adult animal groups at 3, 7 and 28 days post
injury similar to what we found. Through the normalization data, we postulate that since the
aged brain already has a higher baseline of IBA1 optical intensity, changes in IBA1 expression
following injury were decreased due to the aged brain’s pro-inflammatory homeostatic state.

Astrocytic response in young adult and aged brains following injury

Astrocytes are the predominant cell type of the nervous system, and they contribute many
important neuroregulatory functions including regulation of neuron communication,
neurosecretion, metabolism and synaptic plasticity (Mahesh et al., 2006). The wide ranges of
astrocyte functions contribute to uncertainty whether these cells exert beneficial or detrimental
effects after CNS injuries (Sandhir et al., 2008). It has been seen that astrocytes respond to TBI
by pronounced changes in gene expression, cellular hypertrophy and cell proliferation, all of
which occur in a graduated fashion in relation to the severity of the injury (Myer et al., 2006).
Beneficially, studies have shown that reactive astrocytes following TBI form a protective scar to
contain brain injury, provide and improve niche for reparative responses, restore the integrity of
the blood brain barrier, and aid in the establishment of an environment that is helpful for neurite
outgrowth, synaptogenesis and synapse maturation through modulate levels of matrix
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metalloproteinase-3 released (Sofroniew, 2005; Bush et al., 1999; Myer et al., 2006; Reeves et
al., 2002; Falo et al., 2006). However, as astrocytes are known to regulate extracellular
glutamate excitoxicity within the brain due to their expression of GLT-1 and GLAST receptors
which serve as glutamate transporters (Pawlak et al., 2005); after injury, these receptors are
downregulated following experimental TBI in rodents suggesting that this may lead to an
increased inflammation and exacerbated excitotoxicity (Rao et al., 1998). Astrocytes also
release and respond to pro-inflammatory cytokines such as TNF-α, Fas, and IL-1β and therefore,
further amplifying the inflammatory response following TBI (Laird et al., 2010).
In a study done by Sandhir et al. (2008), following injury GFAP mRNA expression levels
were increased and peaked at the 7 days post injury and the aged animal groups showed
significantly higher GFAP mRNA levels compared to the young adult animal groups. Our study
found similar trend of injury-enhanced GFAP expression at the protein level especially in the
young adult brain. The differences we found that aged brain had lower level of GFAP
expression compared to younger brains maybe due to the intensity of the injury, the TBI model
differences, differences in quantification method, as well as disparities between mRNAs and
proteins. Interestingly, when we looked at the normalized data that measured the changes in
GFAP expression at each time point, we observed that aged animals exhibited greater changes of
GFAP optical intensity relative to sham groups at each time point following injury. The function
of astrocytes in the injured brain has been under intensive studies in the past. Previously,
reactive astrocytes were considered detrimental. However, in recent years, the beneficial role of
reactive astrocytes has been recognized. Studies have shown that astrocyte activation following
injury plays important roles in stabilization of injured environment and contribute to recovery
(Floyd and Lyeth, 2007.). For example, transgenic mice with deletions for reactive astrocytes
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actually responded worse to trauma and insult (Myer et al., 2006). In our study, the increased
changes of GFAP expression in the aged brain may correlate to the worse functional recovery we
previously observed in the injured aged group.

Inflammation reduces neurogenic potential and shows increased dividing microglia following
injury in the aged brain

With aging, as with other organs in our body, the brain exhibits a progressive decline in
its regenerative abilities leading to functional deterioration and poorer recovery from injury and
disease. Inflammation is shown to affect neurogenesis in both the SGZ and the SVZ (Pluchino et
al., 2008). Many studies have shown that the immune reaction is able to perturb adult NSCs
activity and fate through the released signaling molecules such as the complex cascade of both
pro-inflammatory and anti-inflammatory cytokines and chemokines (Carpentier and Palmer,
2009). Exaggerated inflammation can also interfere with neuroplasticity as the brain attempts to
recover from injury along with memory consolidation and hippocampal neurogenesis (Barrientos
et al., 2006; Vallieres et al., 2002). Studies have shown that inflammation has a strong negative
effect on neurogenesis in the adult brain due to the impact of the pro-inflammatory cytokines that
are released following the acute injury or disease. The role of pro-inflammatory cytokines
produced by activated microgla from the acute innate inflammatory response such as IL-6, IFNγ, IL-1β, and TNF-α play a pivtol role in suppressing neurogenesis.
We previously found that injury induces significant cell proliferation in the DG and many
of these newly generated cells become neurons in the young adult brain contributing to the innate
cognitive recovery following injury (Sun et al., 2005, 2007). In this study, we found that at 28
days post injury, around 80% of injury-induced new cells became microglial cells in the aged
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brain which was significantly higher than what was observed in the younger adult brain where
40% BrdU/Iba1 double-labeling was found. Conversely, there were much less new neurons
generated in the injured aged brain compared to the younger brains. As we previously observed,
the aged brain retains cell proliferative capacity but generates less new neurons following injury
compared to younger brains. Results from the current study suggest that the endogenous
regenerative potential is decreased in the aged brain. In BrdU/Iba1 double-labeling study, we
found that many of the proliferation cells at 3 days post injury were labeled with IBA1 in both
young and aged injured brains, this probably reflects the rapid proliferation of microglia
following injury. We postulate that microglia may continue to proliferate in the aged brains at
the 28 dpi time point because microglia and neurons have different precursor cells. Therefore,
the BrdU labeling portion may reflect the mitotic properties of microglia.

The effect of minocycline treatment on the glial cell response following TBI

Following injury or disease, a number of studies have reported the anti-inflammatory
effects of minocycline. It has been suggested that minocycline’s effectiveness is largely due to
its superior penetration of the blood-brain barrier (Saivin and Hovin, 1988; Yrjanheikki et al.,
1998). In our study, we found that a short 3-day minocycline treatment increased the levels of
GFAP expression and decrease Iba1 expression in both young and aged animal groups at 3 days
post-injury showing a positive effect in the injured hippocampus.
Minocycline influences neutrophils, monocytes, microglia and neurons during
inflammation by inhibiting neutrophil migration, degranulation and the formation of oxygen free
radicals (Golub et al., 1991). Despite the fact that the mechanisms of action for minocycline
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treatments have not been fully understood, the beneficial effects stem from the drug’s ability in
decreasing or inhibiting microglia activation and proliferation along with the down-regulation of
inducible nitric oxide (iNOS) synthase transcription (Yrjanheikki et al., 1998).
In the current preliminary study, we found that the effect of minocycline was consistent
with the reports from the literature on reducing microglial activation in both young and aged
animal groups. It is unknown whether reduced microglia activation and increased astrocytic
activation by minocyline treatment would encourage neurogenesis. Published studies have
shown mixed results of minocycline on neurogenesis. A study conducted by Ekdahl et al. (2003)
studied minocycline’s effects on neurogenesis in a status epilepticus experiments and found that
in the SE model, minocycline increased the numbers of new neurons in the SGZ/GCL but did not
see an increase in the number of matured neurons or increased injury induced cell proliferation.
Minocycline had a clear effect after TBI, but there was no difference in the trends observed
between aged groups.

Conclusion

In summary, our studies have examined injury-induced astrocyte and microglia cell
responses in the young adult and aged brain at different time points post TBI. We have found
similar trend of glial cell response in the injured brain in both age groups, and found that the
aged brain has an increased microglia response and a decreased astrocytic cell response
compared to the younger brain. The differences in glial cell responses between the two age
groups may correlate to the differences in their regenerative and recovery potential following
injury.
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